T cell responses in coinfection with Onchocerca volvulus and the human immunodeficiency virus type 1.
Onchocerca volvulus and the human immunodeficiency virus (HIV) are two immunocompromising infectious agents of major public health concern in Uganda. To examine the effect of coinfection with O. volvulus and HIV on cellular immune responses, lymphocyte proliferative responses and cytokine production of peripheral blood mononuclear cells (PBMC) from persons infected with O. volvulus with and without HIV type 1 infection were compared. Proliferation of PBMC to PHA and tuberculin (PPD) in coinfection was less (P = 0.08, P < 0.01) than in O. volvulus infection. O. volvulus extract stimulated lymphocyte proliferation in microfilaria-negative and HIV-negative O. volvulus infection while only an inconspicuous response was observed in microfilaria-negative coinfection. After stimulation of PBMC with PPD, the production of interferon-gamma (IFN-gamma), interleukin (IL)-4 and IL-5-demonstrated in O. volvulus infection-were reduced in coinfection with HIV (P < 0.01). While both groups failed to produce IFN-gamma in response to O. volvulus extract, only O. volvulus infected persons generated pronounced IL-5 and low IL-4 levels (0.01 > P = 0.02). The cellular immune responses in coinfection suggested an HIV-related lack of specific reactivity to O. volvulus antigen and impairment of IL-4 and IL-5 production in addition to the lack of IFN-gamma response on antigenic stimulation.
Sentongo
E
E
Department of Helminthology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
Rubaale
T
T
Büttner
D W
DW
Brattig
N W
NW
D000328:Adult; D000818:Animals; D000947:Antigens, Helminth / Q000008:administration & dosage; D016207:Cytokines / Q000096:biosynthesis; D005260:Female; D015658:HIV Infections / Q000150:complications* / Q000276:immunology*; D015497:HIV-1; D006801:Humans; D007111:Immunity, Cellular; D008213:Lymphocyte Activation; D008297:Male; D017181:Onchocerca volvulus / Q000276:immunology; D009855:Onchocerciasis / Q000150:complications* / Q000276:immunology*; D010835:Phytohemagglutinins / Q000494:pharmacology; D013601:T-Lymphocytes / Q000276:immunology*; D014373:Tuberculin / Q000494:pharmacology; D014454:Uganda
D000947:Antigens, Helminth; D016207:Cytokines; D010835:Phytohemagglutinins; D014373:Tuberculin